Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in Thailand: A Cost-Effectiveness Study

Author： Luangasanatip Nantasit   Chaiyakunapruk Nathorn   Upakdee Nilawan   Wong Peerapon  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.7, 2011-07, pp. : 493-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective

By Delea Thomas E.  

PharmacoEconomics, Vol. 25, Iss. 4, 2007-01 ,pp. : 329-342

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain

By Plans-Rubió Pedro  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

Deferiprone: Transfusion-Dependent Diseases

By Barman Balfour J.A.   Foster R.H.  

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 553-578

Adis International

Access to resources Recommend Favorite

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes   Brown Ruth E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma

By Ya-Chen Tina Shih  

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 577-590

Adis International

Access to resources Recommend Favorite